2023-08-14 09:53:11 ET
- Instil Bio press release ( NASDAQ: TIL ): Q2 GAAP EPS of -$0.14.
- As of June 30, 2023, Instil had cash, cash equivalents, restricted cash and marketable securities of $202.9 million, which consists of $21.8 million in cash and cash equivalents, $1.2 million in restricted cash and $179.9 million in marketable securities, compared to $260.9 million in total cash and cash equivalents and marketable securities, consisting of $43.7 million in cash and cash equivalents and $217.2 million in marketable securities as of December 31, 2022.
For further details see:
Instil Bio GAAP EPS of -$0.14